Literature DB >> 9447239

The molecular basis of amyloidosis.

L C Serpell1, M Sunde, C C Blake.   

Abstract

Amyloidoses are diseases, including some currently prominent such as Alzheimer's disease, bovine spongiform encephalophaty (BSE) and Type II diabetes, in which soluble proteins are deposited in a specific, highly stable, fibrillar form. The amyloid fibrils are made up of protofilaments whose molecular structure is composed of pairs of beta-sheets in a helical form that allows them to be continuously hydrogen-bonded along the length of the fibril. The observation that similar fibrils are generated from different proteins indicates that fibril formation is accompanied by structural conversion. The transmissible spongiform encephalopathies, such as BSE and kuru, involve an infectious agent identified with the prion protein. The properties of the agent are more consistent with prion amyloid than the protein itself, suggesting infectivity in these diseases in equivalent to the 'seeding' of amyloid fibrils at a new site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9447239     DOI: 10.1007/s000180050107

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  27 in total

1.  Ultrastructural organization of amyloid fibrils by atomic force microscopy.

Authors:  A K Chamberlain; C E MacPhee; J Zurdo; L A Morozova-Roche; H A Hill; C M Dobson; J J Davis
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro.

Authors:  M Ramirez-Alvarado; J S Merkel; L Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy.

Authors:  A K Chamberlain; V Receveur; A Spencer; C Redfield; C M Dobson
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

4.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

5.  Freezing of a fish antifreeze protein results in amyloid fibril formation.

Authors:  Steffen P Graether; Carolyn M Slupsky; Brian D Sykes
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

6.  Characterizing the assembly of the Sup35 yeast prion fragment, GNNQQNY: structural changes accompany a fiber-to-crystal switch.

Authors:  Karen E Marshall; Matthew R Hicks; Thomas L Williams; Søren Vrønning Hoffmann; Alison Rodger; Timothy R Dafforn; Louise C Serpell
Journal:  Biophys J       Date:  2010-01-20       Impact factor: 4.033

7.  Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.

Authors:  Martino Calamai; Fabrizio Chiti; Christopher M Dobson
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

8.  What determines the structure and stability of KFFE monomers, dimers, and protofibrils?

Authors:  Giovanni Bellesia; Joan-Emma Shea
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

9.  [NSI+] determinant has a pleiotropic phenotypic manifestation that is modulated by SUP35, SUP45, and VTS1 genes.

Authors:  Anton A Nizhnikov; Zalina M Magomedova; Alexandr A Rubel; Alexandra M Kondrashkina; Sergey G Inge-Vechtomov; Alexey P Galkin
Journal:  Curr Genet       Date:  2012-01-04       Impact factor: 3.886

Review 10.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Authors:  A Clark; M R Nilsson
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.